Adverse Events in a Breastfed Infant Exposed to Risperidone and Haloperidol

Breastfeed Med. 2019 Nov;14(9):683-684. doi: 10.1089/bfm.2019.0093. Epub 2019 May 28.

Abstract

Schizophrenia and related psychoses are characterized by high recurrence rates and a serious impact on social functions. Many patients with these conditions, therefore, require prophylactic treatment during the postpartum period. Antipsychotic medication is the main treatment strategy for these disorders. Compared with single use of antipsychotics, data on the safety of combined antipsychotics on the breastfed infants are very limited. The current report presents adverse events in an infant exposed to a combination of risperidone and haloperidol through breast milk.

Keywords: antipsychotics; haloperidol; lactation; risperidone.

Publication types

  • Case Reports

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Dietary Exposure / adverse effects*
  • Drug Therapy, Combination
  • Female
  • Haloperidol / adverse effects*
  • Humans
  • Infant, Newborn
  • Milk, Human / chemistry*
  • Pregnancy
  • Risperidone / adverse effects*
  • Schizophrenia / drug therapy*
  • Young Adult

Substances

  • Antipsychotic Agents
  • Haloperidol
  • Risperidone